Severity of a COVID-19 illness could be determined by examining autoantibodies in the nasal cavity, allowing more personalized treatment protocols. Severe COVID-19 can be life-threatening for patients ...
As respiratory viruses begin circulating across Canada, many families are left wondering what to do when illness strikes at home. To help provide greater clarity, Abbott (NYSE: ABT) today announced ...
CoV-2, the virus that causes COVID-19, and Influenza A and Influenza B from one nasal swab. Abbott Panbio COVID-19/Flu A&B ...
A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially ...
A nasal swab kit that allows individuals to collect their own samples for COVID-19 diagnostic testing has been granted an emergency use authorization (EUA) by the US Food and Drug Administration (FDA) ...
Abbott ( ABT) announced the availability of its Panbio COVID-19/Flu A&B Self-Test across Canada, offering families a way to check for COVID-19 and influenza A and B using a single nasal swab. The test ...
LetsGetChecked has announced that the US Food and Drug Administration (FDA) has authorised the use of its home collection Covid-19 test, which is now available without a prescription. The test will be ...
March, when the World Health Organization declared that the outbreak of a pneumonia-like disease called COVID-19 had reached ...
New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans. A wide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results